Legal Representation
Attorney
Amanda R. Lippes
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 21, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 20, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 4, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 18, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jan 17, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 17, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 6, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 6, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 6, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 6, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 28, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 27, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 27, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 27, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 19, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 25, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 25, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 5, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 17, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 17, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 23, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 22, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 7, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 010
Medical apparatus for facilitating administration of pharmaceutical preparations used in the prevention and treatment of respiratory distress syndrome in infants
Additional Information
Design Mark
The mark consists of the wording "INFASURFPROVIA" in a stylized font, wherein the first "I", "P", and "V" are capitalized, and a tilde shaped line extends over "PROV".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
010